» Articles » PMID: 34737870

Research Priorities to Address the Global Burden of Chronic Obstructive Pulmonary Disease (COPD) in the Next Decade

Abstract

Background: The global prevalence of chronic obstructive pulmonary disease (COPD) has increased markedly in recent decades. Given the scarcity of resources available to address global health challenges and respiratory medicine being relatively under-invested in, it is important to define research priorities for COPD globally. In this paper, we aim to identify a ranked set of COPD research priorities that need to be addressed in the next 10 years to substantially reduce the global impact of COPD.

Methods: We adapted the Child Health and Nutrition Research Initiative (CHNRI) methodology to identify global COPD research priorities.

Results: 62 experts contributed 230 research ideas, which were scored by 34 researchers according to six pre-defined criteria: answerability, effectiveness, feasibility, deliverability, burden reduction, and equity. The top-ranked research priority was the need for new effective strategies to support smoking cessation. Of the top 20 overall research priorities, six were focused on feasible and cost-effective pulmonary rehabilitation delivery and access, particularly in primary/community care and low-resource settings. Three of the top 10 overall priorities called for research on improved screening and accurate diagnostic methods for COPD in low-resource primary care settings. Further ideas that drew support involved a better understanding of risk factors for COPD, development of effective training programmes for health workers and physicians in low resource settings, and evaluation of novel interventions to encourage physical activity.

Conclusions: The experts agreed that the most pressing feasible research questions to address in the next decade for COPD reduction were on prevention, diagnosis and rehabilitation of COPD, especially in low resource settings. The largest gains should be expected in low- and middle-income countries (LMIC) settings, as the large majority of COPD deaths occur in those settings. Research priorities identified by this systematic international process should inform and motivate policymakers, funders, and researchers to support and conduct research to reduce the global burden of COPD.

Citing Articles

Addressing barriers to global multidisciplinary stakeholder inclusivity: Lessons from global orofacial cleft research priority setting.

Kouvroukoglou N, Sandhu S, Delage B, Sell D, Stock N, Davies G J Glob Health. 2024; 14:04261.

PMID: 39666584 PMC: 11636950. DOI: 10.7189/jogh.14.04261.


Understanding the Risk Factors, Burden, and Interventions for Chronic Respiratory Diseases in Low- and Middle-Income Countries: A Scoping Review.

Boutros P, Kassem N, Boudo V, Sie A, Munga S, Maggioni M Public Health Rev. 2024; 45:1607339.

PMID: 39544625 PMC: 11560431. DOI: 10.3389/phrs.2024.1607339.


Global respiratory health priorities at the beginning of the 21st century.

M Greene C, Abdulkadir M Eur Respir Rev. 2024; 33(172).

PMID: 38599674 PMC: 11004770. DOI: 10.1183/16000617.0205-2023.


Isolated small airways obstruction predicts future chronic airflow obstruction: a multinational longitudinal study.

Knox-Brown B, Potts J, Quintero Santofimio V, Minelli C, Patel J, Abass N BMJ Open Respir Res. 2023; 10(1).

PMID: 37989490 PMC: 10660204. DOI: 10.1136/bmjresp-2023-002056.


Nortriptyline Modulates the Migration of Peripheral Blood Lymphocytes and Monocytes in Patients with Chronic Obstructive Pulmonary Disease.

Kadushkin A, Tahanovich A, Movchan L, Kolesnikova T, Khadasouskaya E, Shman T Dokl Biochem Biophys. 2023; 507(1):307-311.

PMID: 36786992 DOI: 10.1134/S1607672922050076.


References
1.
Rabe K, Watz H . Chronic obstructive pulmonary disease. Lancet. 2017; 389(10082):1931-1940. DOI: 10.1016/S0140-6736(17)31222-9. View

2.
Vos T, Flaxman A, Naghavi M, Lozano R, Michaud C, Ezzati M . Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2163-96. PMC: 6350784. DOI: 10.1016/S0140-6736(12)61729-2. View

3.
Collins P, Patel V, Joestl S, March D, Insel T, Daar A . Grand challenges in global mental health. Nature. 2011; 475(7354):27-30. PMC: 3173804. DOI: 10.1038/475027a. View

4.
Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E . Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health. 2016; 5(2):020415. PMC: 4693508. DOI: 10.7189/jogh.05.020415. View

5.
Decramer M, Janssens W, Miravitlles M . Chronic obstructive pulmonary disease. Lancet. 2012; 379(9823):1341-51. PMC: 7172377. DOI: 10.1016/S0140-6736(11)60968-9. View